Table 2.
Serum Anti-Listerial IgG ELISA Titers (rLLO).
Groups | Weeks after Lmdd-HIV-gag immunization | |||||||
---|---|---|---|---|---|---|---|---|
Naive | 0 | 6 | 12 | 19 | 21 | 23 | 33 | 34 |
RAm-9 | 200 | 400 | 200 | 200 | 200 | 200 | 200 | 400 |
RHm-9 | 200 | 400 | 400 | 200 | 200 | 200 | 200 | 200 |
Vector Control | ||||||||
RSg-8 | 200 | 400 | 400 | 400 | 400 | 400 | 400 | 400 |
RUg-8 | 200 | 200 | 200 | 400 | 800 | 400 | 400 | 400 |
RMh-8 | 400 | 400 | 400 | 400 | 800 | 400 | 200 | 200 |
Anti-Listerial IgG ELISA conducted using recombinant His-tagged Listeriolysin (LLO) as described [17].